SAT0110 Efficacy and Safety of Pateclizumab (Anti-Lymphotoxin-Alpha) in Dmard-Ir Patients: Results of a Randomized, Double-Blind, Placebo-Controlled Head-To-Head Phase 2 Study with Adalimumab

W. Kennedy; P. Horn; Z. Su; K. Basu; A. Herman; A. Song; M. Townsend; J. Xiao; J. Grogan; M. Derby; J. A. Simon-Campos; J. Davis

doi:10.1136/annrheumdis-2013-eular.1836

SAT0110 Efficacy and Safety of Pateclizumab (Anti-Lymphotoxin-Alpha) in Dmard-Ir Patients: Results of a Randomized, Double-Blind, Placebo-Controlled Head-To-Head Phase 2 Study with Adalimumab

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1836 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A617.2-A618

Author(s):

W. Kennedy ◽

P. Horn ◽

Z. Su ◽

K. Basu ◽

A. Herman ◽

...

Keyword(s):

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study ◽

Lymphotoxin Alpha

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734506216.793579336 ◽

2020 ◽

Author(s):

Nathalie Gaspar

Keyword(s):

Adult Patients ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Metastatic Osteosarcoma ◽

Phase 2 Study

Download Full-text

Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Active Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study

SSRN Electronic Journal ◽

10.2139/ssrn.3523879 ◽

2020 ◽

Author(s):

Yoshiya Tanaka ◽

Tsutomu Takeuchi ◽

Hisashi Yamanaka ◽

Toshihiro Nanki ◽

Hisanori Umehara ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of maintenance therapy with anti-TA-MUC1 monoclonal antibody PankoMab after chemotherapy in patients with recurrent epithelial ovarian carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps5622 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS5622-TPS5622

Author(s):

Jonathan A. Ledermann ◽

Ingo von Broen ◽

Frank Zimmermann ◽

Johannes Nippgen ◽

Steffen Goletz

Keyword(s):

Monoclonal Antibody ◽

Maintenance Therapy ◽

Ovarian Carcinoma ◽

Epithelial Ovarian Carcinoma ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide

Journal of Hematology & Oncology ◽

10.1186/1756-8722-5-71 ◽

2012 ◽

Vol 5 (1) ◽

Cited By ~ 39

Author(s):

Eunice S Wang ◽

Roger M Lyons ◽

Richard A Larson ◽

Sunil Gandhi ◽

Delong Liu ◽

...

Keyword(s):

Myelodysplastic Syndrome ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Active Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Results of a Randomized, Double‐blind, Placebo‐controlled Phase 2 study

Arthritis & Rheumatology ◽

10.1002/art.41555 ◽

2020 ◽

Author(s):

Yoshiya Tanaka ◽

Tsutomu Takeuchi ◽

Hisashi Yamanaka ◽

Toshihiro Nanki ◽

Hisanori Umehara ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

1023-96 A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(04)91080-7 ◽

2004 ◽

Vol 43 (5) ◽

pp. A254

Author(s):

Ralph M Vicari ◽

Bernard Chaitman ◽

Deborah Keefe ◽

William B Smith ◽

Steven G Chrysant ◽

...

Keyword(s):

Stable Angina ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

Diabetes Care ◽

10.2337/dc14-1044 ◽

2014 ◽

Vol 37 (12) ◽

pp. 3253-3261 ◽

Cited By ~ 43

Author(s):

Aaron Vinik ◽

Julio Rosenstock ◽

Uma Sharma ◽

Karen Feins ◽

Ching Hsu ◽

...

Keyword(s):

Neuropathic Pain ◽

Phase 2 ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Active Comparator ◽

Phase 2 Study

Download Full-text

O4-11-06: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE

Alzheimer s & Dementia ◽

10.1016/j.jalz.2014.04.450 ◽

2014 ◽

Vol 10 ◽

pp. P275-P275 ◽

Cited By ~ 14

Author(s):

Jeffrey Cummings ◽

William Cho ◽

Michael Ward ◽

Michel Friesenhahn ◽

Flavia Brunstein ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma

Annals of Oncology ◽

10.1093/annonc/mdx440.035 ◽

2017 ◽

Vol 28 ◽

pp. v626 ◽

Cited By ~ 6

Author(s):

J. Ledermann ◽

J. Sehouli ◽

B. Zurawski ◽

F. Raspagliesi ◽

U. De Giorgi ◽

...

Keyword(s):

Maintenance Therapy ◽

Ovarian Carcinoma ◽

Epithelial Ovarian Carcinoma ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study ◽

Switch Maintenance Therapy ◽

Randomized Phase 2

Download Full-text

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

The Lancet Oncology ◽

10.1016/s1470-2045(18)30742-3 ◽

2019 ◽

Vol 20 (1) ◽

pp. 120-133 ◽

Cited By ~ 68

Author(s):

Florence Duffaud ◽

Olivier Mir ◽

Pascaline Boudou-Rouquette ◽

Sophie Piperno-Neumann ◽

Nicolas Penel ◽

...

Keyword(s):

Adult Patients ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Metastatic Osteosarcoma ◽

Phase 2 Study

Download Full-text